Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ashwagandha as Adjunct Therapy in Schizophrenia
NCT07541157Completed
- Sponsor
- Hasanuddin University
- Start
- Sep 2025
- Primary completion
- Jan 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial in schizophrenia (2 arms), sponsored by Hasanuddin University. Primary endpoints: Change in serum Brain-Derived Neurotrophic Factor levels at 8 weeks and Change in cognitive function (Montreal Cognitive Assessment Indonesian Version score) at 8 weeks. Started Sep 2025; status: completed.
02
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT07541157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07541157.